| |
 |
Editorial:Hot Topic: [Anti-Cancer Drugs(Executive Editor: Elke Bergmann-Leitner)]
|
| |
|
pp.730-731 (2) Author: Elke Bergmann-Leitner
|
| |
|
|
| |
|
Prodigiosins as Anti Cancer Agents: Living Upto Their Name
|
| |
|
pp.732-741 (10) Authors: R. Pandey, R. Chander, K. B. Sainis
|
| |
|
|
| |
|
Chemokine Receptors as Targets for Cancer Therapy
|
| |
|
pp.742-757 (16) Authors: Xuesong Wu, Vivian C. Lee, Eric Chevalier, Sam T. Hwang
|
| |
|
|
| |
|
Receptor Tryosine Kinase Inhibitors as Potent Weapons in War Against Cancers
|
| |
|
pp.758-776 (19) Authors: P. Sapra Sharma, R. Sharma, T. Tyagi
|
| |
|
|
| |
|
Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
|
| |
|
pp.777-791 (15) Authors: Di Chen, Vesna Milacic, Michael Frezza, Q. Ping Dou
|
| |
|
|
| |
|
Chemosensitization and Immunosensitization of Resistant Cancer Cells to Apoptosis and Inhibition of Metastasis by the Specific NF-κB Inhibitor DHMEQ
|
| |
|
pp.792-808 (17) Authors: Alina Katsman, Kazuo Umezawa, Benjamin Bonavida
|
| |
|
|
| |
|
Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
|
| |
|
pp.809-825 (17) Author: Sven Mostbock
|
| |
|
|
